{"id":"https://openalex.org/W4283755864","doi":"https://doi.org/10.54101/acen.2022.2.8","title":"Safety of pathogenetic therapy for multiple sclerosis during the COVID-19 pandemic","display_name":"Safety of pathogenetic therapy for multiple sclerosis during the COVID-19 pandemic","publication_year":2022,"publication_date":"2022-06-30","ids":{"openalex":"https://openalex.org/W4283755864","doi":"https://doi.org/10.54101/acen.2022.2.8"},"language":"en","primary_location":{"id":"doi:10.54101/acen.2022.2.8","doi":"https://doi.org/10.54101/acen.2022.2.8","is_oa":true,"landing_page_url":"https://doi.org/10.54101/acen.2022.2.8","pdf_url":"https://annaly-nevrologii.com/journal/pathID/article/download/863/634","source":{"id":"https://openalex.org/S4210238735","display_name":"Annals of Clinical and Experimental Neurology","issn_l":"2075-5473","issn":["2075-5473","2409-2533"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","norway-1","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Clinical and Experimental Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://annaly-nevrologii.com/journal/pathID/article/download/863/634","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090219209","display_name":"Andrey M. Petrov","orcid":"https://orcid.org/0000-0001-9648-5492","observed_orcids":["https://orcid.org/0000-0001-9648-5492"]},"institutions":[{"id":"https://openalex.org/I4210105947","display_name":"Institute of the Human Brain","ror":"https://ror.org/01ska0903","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210105947","https://openalex.org/I4210115279"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Andrey M. Petrov","raw_affiliation_strings":["N.P. Be\u0441htereva Institute of Human Brain of the Russian Academy of Sciences"],"raw_orcid":"https://orcid.org/0000-0001-9648-5492","affiliations":[{"raw_affiliation_string":"N.P. Be\u0441htereva Institute of Human Brain of the Russian Academy of Sciences","institution_ids":["https://openalex.org/I4210105947"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073269865","display_name":"\u041c. \u0412. \u0412\u043e\u0442\u0438\u043d\u0446\u0435\u0432\u0430","orcid":"https://orcid.org/0000-0002-0728-8903","observed_orcids":["https://orcid.org/0000-0002-0728-8903"]},"institutions":[{"id":"https://openalex.org/I4210105947","display_name":"Institute of the Human Brain","ror":"https://ror.org/01ska0903","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210105947","https://openalex.org/I4210115279"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Marina V. Votintseva","raw_affiliation_strings":["N.P. Be\u0441htereva Institute of Human Brain of the Russian Academy of Sciences"],"raw_orcid":"https://orcid.org/0000-0002-0728-8903","affiliations":[{"raw_affiliation_string":"N.P. Be\u0441htereva Institute of Human Brain of the Russian Academy of Sciences","institution_ids":["https://openalex.org/I4210105947"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112346940","display_name":"Igor D. Stolyarov","orcid":"https://orcid.org/0000-0001-8154-9107","observed_orcids":["https://orcid.org/0000-0001-8154-9107"]},"institutions":[{"id":"https://openalex.org/I4210105947","display_name":"Institute of the Human Brain","ror":"https://ror.org/01ska0903","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210105947","https://openalex.org/I4210115279"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Igor D. Stolyarov","raw_affiliation_strings":["N.P. Be\u0441htereva Institute of Human Brain of the Russian Academy of Sciences"],"raw_orcid":"https://orcid.org/0000-0001-8154-9107","affiliations":[{"raw_affiliation_string":"N.P. Be\u0441htereva Institute of Human Brain of the Russian Academy of Sciences","institution_ids":["https://openalex.org/I4210105947"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210105947"],"apc_list":null,"apc_paid":null,"fwci":0.138,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.36807796,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"16","issue":"2","first_page":"70","last_page":"77"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":1.0},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9139999747276306},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.718999981880188},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7879999876022339},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7450000047683716},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.8090000152587891},{"id":"https://openalex.org/keywords/glatiramer-acetate","display_name":"glatiramer acetate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":0.8980000019073486},{"id":"https://openalex.org/keywords/ocrelizumab","display_name":"ocrelizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/fingolimod","display_name":"fingolimod","score":0.9649999737739563},{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cladribine","display_name":"cladribine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/teriflunomide","display_name":"teriflunomide","score":0.9129999876022339},{"id":"https://openalex.org/keywords/dimethyl-fumarate","display_name":"dimethyl fumarate","score":0.9940000176429749},{"id":"https://openalex.org/keywords/safety-monitoring","display_name":"safety monitoring","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.8867132663726807},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8539029955863953},{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.8092162013053894},{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.79549241065979},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7444076538085938},{"id":"https://openalex.org/C2777703276","wikidata":"https://www.wikidata.org/wiki/Q3077133","display_name":"Teriflunomide","level":4,"score":0.7300454378128052},{"id":"https://openalex.org/C2778577042","wikidata":"https://www.wikidata.org/wiki/Q418274","display_name":"Glatiramer acetate","level":3,"score":0.6490157246589661},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.5816463232040405},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5743670463562012},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.5198248624801636},{"id":"https://openalex.org/C2780644213","wikidata":"https://www.wikidata.org/wiki/Q704930","display_name":"Progressive multifocal leukoencephalopathy","level":3,"score":0.49917054176330566},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4097744822502136},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31920096278190613},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.3129701316356659},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2846222221851349},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2618657350540161},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21686050295829773},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.08684757351875305},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.54101/acen.2022.2.8","doi":"https://doi.org/10.54101/acen.2022.2.8","is_oa":true,"landing_page_url":"https://doi.org/10.54101/acen.2022.2.8","pdf_url":"https://annaly-nevrologii.com/journal/pathID/article/download/863/634","source":{"id":"https://openalex.org/S4210238735","display_name":"Annals of Clinical and Experimental Neurology","issn_l":"2075-5473","issn":["2075-5473","2409-2533"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","norway-1","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Clinical and Experimental Neurology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:d5ea4d010a944a7599679a06cb7b9c9e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d5ea4d010a944a7599679a06cb7b9c9e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0410\u043d\u043d\u0430\u043b\u044b \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0438 \u044d\u043a\u0441\u043f\u0435\u0440\u0438\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u043e\u0439 \u043d\u0435\u0432\u0440\u043e\u043b\u043e\u0433\u0438\u0438, Vol 16, Iss 2, Pp 70-77 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.54101/acen.2022.2.8","doi":"https://doi.org/10.54101/acen.2022.2.8","is_oa":true,"landing_page_url":"https://doi.org/10.54101/acen.2022.2.8","pdf_url":"https://annaly-nevrologii.com/journal/pathID/article/download/863/634","source":{"id":"https://openalex.org/S4210238735","display_name":"Annals of Clinical and Experimental Neurology","issn_l":"2075-5473","issn":["2075-5473","2409-2533"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","norway-1","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Clinical and Experimental Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283755864.pdf","grobid_xml":"https://content.openalex.org/works/W4283755864.grobid-xml"},"referenced_works_count":82,"referenced_works":["https://openalex.org/W2158202057","https://openalex.org/W2330187205","https://openalex.org/W2336394176","https://openalex.org/W2342329243","https://openalex.org/W2552609792","https://openalex.org/W2900596677","https://openalex.org/W2905623440","https://openalex.org/W2912817025","https://openalex.org/W2914770914","https://openalex.org/W2994902810","https://openalex.org/W3001118548","https://openalex.org/W3012421327","https://openalex.org/W3013987649","https://openalex.org/W3014441189","https://openalex.org/W3015217327","https://openalex.org/W3015705209","https://openalex.org/W3016127017","https://openalex.org/W3016673289","https://openalex.org/W3019181748","https://openalex.org/W3019661626","https://openalex.org/W3019732410","https://openalex.org/W3021812017","https://openalex.org/W3022045875","https://openalex.org/W3023561439","https://openalex.org/W3024442031","https://openalex.org/W3024790435","https://openalex.org/W3024844647","https://openalex.org/W3025715263","https://openalex.org/W3025860919","https://openalex.org/W3030121249","https://openalex.org/W3035911233","https://openalex.org/W3037709082","https://openalex.org/W3037930397","https://openalex.org/W3039522166","https://openalex.org/W3042482358","https://openalex.org/W3042645700","https://openalex.org/W3043247721","https://openalex.org/W3043467580","https://openalex.org/W3043490954","https://openalex.org/W3048285835","https://openalex.org/W3048952843","https://openalex.org/W3080204060","https://openalex.org/W3087674230","https://openalex.org/W3087862874","https://openalex.org/W3088256443","https://openalex.org/W3089727605","https://openalex.org/W3091085673","https://openalex.org/W3092307577","https://openalex.org/W3093483089","https://openalex.org/W3096317085","https://openalex.org/W3099910576","https://openalex.org/W3107305002","https://openalex.org/W3112105690","https://openalex.org/W3115435993","https://openalex.org/W3115528239","https://openalex.org/W3119308228","https://openalex.org/W3119914237","https://openalex.org/W3121271234","https://openalex.org/W3121831652","https://openalex.org/W3122198373","https://openalex.org/W3122553121","https://openalex.org/W3125785558","https://openalex.org/W3127226135","https://openalex.org/W3131710052","https://openalex.org/W3134880722","https://openalex.org/W3136845163","https://openalex.org/W3137299005","https://openalex.org/W3137873237","https://openalex.org/W3139311115","https://openalex.org/W3140880290","https://openalex.org/W3152791742","https://openalex.org/W3155816660","https://openalex.org/W3164186480","https://openalex.org/W3165838540","https://openalex.org/W3174207847","https://openalex.org/W3175848779","https://openalex.org/W3177818710","https://openalex.org/W3186393771","https://openalex.org/W3203634332","https://openalex.org/W3204061559","https://openalex.org/W3204719726","https://openalex.org/W3216506151"],"related_works":["https://openalex.org/W3136845163","https://openalex.org/W3092300832","https://openalex.org/W4213271125","https://openalex.org/W3048952843","https://openalex.org/W3093899622","https://openalex.org/W3045085843","https://openalex.org/W3042181077","https://openalex.org/W3204505117","https://openalex.org/W4379390440","https://openalex.org/W4396655959"],"abstract_inverted_index":{"The":[0],"safety":[1,34,194],"of":[2,13,30,36,46,57,76,82,96,101,159,171,182,191],"pathogenetic":[3,70,183],"therapy":[4,184],"for":[5,198],"multiple":[6],"sclerosis":[7],"(MS)":[8],"is":[9,60,196],"a":[10,44,61,73,139],"crucial":[11],"aspect":[12],"the":[14,18,28,77,90,94,114,120,169,188,201,206],"therapeutic":[15],"strategy":[16],"during":[17,27,119,200],"COVID-19":[19,121,202],"pandemic.":[20,122],"Based":[21,85],"on":[22,51,86,93,103],"our":[23],"own":[24],"data,":[25],"obtained":[26],"study":[29],"MS":[31,37,172],"pathogenesis":[32],"and":[33,55,110,130,146,161,174,204],"analysis":[35],"disease-modifying":[38],"therapies":[39],"(DMTs),":[40],"we":[41],"hereby":[42],"suggest":[43],"classification":[45],"DMTs":[47,97,199],"side":[48],"effects,":[49],"based":[50],"their":[52],"type,":[53],"development,":[54],"direction":[56],"action.":[58],"There":[59],"need":[62],"to":[63,117,177],"thoroughly":[64],"analyse":[65],"adverse":[66,80],"events":[67],"caused":[68],"by":[69],"therapy,":[71],"with":[72,98,135,138],"balanced":[74],"assessment":[75],"direct":[78],"vs.":[79],"effects":[81],"immunosuppressive":[83],"drugs.":[84],"available":[87],"literature,":[88],"in":[89],"article,":[91],"data":[92],"effect":[95,143],"various":[99],"mechanisms":[100],"action":[102],"severe":[104],"coronavirus":[105],"infection":[106],"are":[107,113,151],"systematized.":[108],"Interferon-":[109],"glatiramer":[111],"acetate":[112],"safest":[115],"drugs":[116,154],"use":[118],"Teriflunomide,":[123],"dimethyl":[124],"fumarate,":[125],"natalizumab,":[126],"ocrelizumab,":[127],"fingolimod,":[128],"alemtuzumab,":[129],"cladribine":[131],"should":[132],"be":[133,166],"used":[134],"caution.":[136],"Drugs":[137],"minor":[140],"systemic":[141],"immunosuppressant":[142],"(e.g.":[144,149],"natalizumab)":[145],"selective":[147],"immunosuppressants":[148],"ocrelizumab)":[150],"safer":[152],"than":[153],"that":[155,168],"cause":[156],"non-selective":[157],"depletion":[158],"T":[160],"B":[162],"cells.":[163],"It":[164],"must":[165],"stressed":[167],"risk":[170,190],"exacerbation":[173],"progression":[175],"due":[176],"untimely":[178],"prescription":[179],"or":[180],"cessation":[181],"can":[185],"significantly":[186],"exceed":[187],"potential":[189],"COVID-19.":[192],"Long-term":[193],"monitoring":[195],"required":[197],"pandemic":[203],"when":[205],"epidemiological":[207],"situation":[208],"stabilizes.":[209]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-07-02T00:00:00"}